Dipika Misra
Expertise in
7
conditions

Dr. Dipika Misra

Oncology | Hematology
125 Queens Road, Suite 520, 
Charlotte, NC 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
7
conditions
125 Queens Road, Suite 520, 
Charlotte, NC 

Overview

Dipika Misra is an Oncologist and a Hematologist practicing medicine in Charlotte, North Carolina.

Dr. Misra is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Inflammatory Breast Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration.

She is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 1 clinical trial. Dr. Misra is currently accepting new patients.

Specialties

Oncology
Hematology

Licenses

Internal Medicine in NY

Hospital Affiliations

Novant Health Mint Hill Medical Center
Novant Health Huntersville Medical Center
Novant Health Ballantyne Medical Center
Novant Health Presbyterian Medical Center
Novant Health Matthews Medical Center

Languages Spoken

English
Spanish
Vietnamese

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Novant Health Cancer Institute - Elizabeth (Breast Cancer)
125 Queens Road, Suite 520, Charlotte, NC 28204

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: August 31, 2026
Intervention Type: Other, Radiation, Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3

1 Total Publications

The Clinical Presentation, Management, and Outcomes of Breast Adenomyoepithelioma: A Single-Institution Experience.
The Clinical Presentation, Management, and Outcomes of Breast Adenomyoepithelioma: A Single-Institution Experience.
Journal: Breast cancer : basic and clinical research
Published: September 08, 2025
Similar Doctors
Expertise in
17
conditions
Dr. Ruben A. Mesa
Hematology | Oncology
Expertise in
17
conditions
Dr. Ruben A. Mesa
Hematology | Oncology
Referral required
Before you request

Atrium Health Levine Cancer Institute

1021 Morehead Medical Drive, 
Charlotte, NC 
 (0.9 miles away)
980-442-2000
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Ruben Mesa is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Mesa is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Myelofibrosis, Polycythemia Vera, Myeloproliferative Neoplasms (MPN), Bone Marrow Transplant, and Splenectomy. Dr. Mesa is board certified in American Board Of Internal Medicine, Hematology. Dr. Mesa is currently accepting new patients.

Expertise in
11
conditions
Dr. Manisha Bhutani
Hematology | Oncology
Expertise in
11
conditions
Dr. Manisha Bhutani
Hematology | Oncology
Referral may be required
Before you request

Atrium Health Levine Cancer Institute (Hematology)

1021 Morehead Medical Drive, Building 2, Suite 60201, 
Charlotte, NC 
 (0.9 miles away)
980-442-4363
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Manisha Bhutani is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Bhutani is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Bhutani is board certified in American Board Of Internal Medicine, Hematology and American Board Of Internal Medicine. Dr. Bhutani is currently accepting new patients.

Expertise in
7
conditions
Dr. Ifeyinwa M. Osunkwo
Hematology | Oncology
Expertise in
7
conditions
Dr. Ifeyinwa M. Osunkwo
Hematology | Oncology
Referral may be required

Office

1021 Morehead Medical Dr, 
Charlotte, NC 
 (0.9 miles away)
980-442-2000
Languages Spoken:
English
See accepted insurances

Ifeyinwa Osunkwo is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Osunkwo is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.

Frequently Asked Questions about Dr. Dipika Misra

How do I make an appointment with Dr. Dipika Misra?

You can book an appointment with Dr. Dipika Misra by calling their office at 980-302-6500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Dipika Misra a top-rated expert for Paget Disease of the Breast?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Dipika Misra is classified as an Distinguished expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Dipika Misra specialize in?

While Dr. Dipika Misra is a Oncology, they have specific expertise in Paget Disease of the Breast, Breast Cancer, and Inflammatory Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Dipika Misra participate in research or clinical trials?

Yes. Dr. Dipika Misra has published 1 articles and abstracts on conditions like Paget Disease of the Breast. You can view a list of Dr. Dipika Misra's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Dipika Misra accept my insurance?

Dr. Dipika Misra accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 980-302-6500 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Misra's expertise for a condition
ConditionClose
    View All 76 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile